Market Place
Sourcing Support
EMA, FDA Begin Reviewing Heartburn Medicines for Carcinogen
13 Sep 2019 //
RAPS
NDEA & NDMA Impurities: Another Indian Manuf. Receives an FDA Warning Letter
13 Aug 2019 //
RAPS
Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply
14 Jun 2019 //
FIERCE PHARMA
Heart Drugs Free From Carcinogens Identified as Recalls Drag On
05 Apr 2019 //
BLOOMBERG
To Prevent Losartan Shortages, FDA Allows Higher Impurity Levels
22 Mar 2019 //
RAPS
FDA updates on recalls of valsartan, losartan and irbesartan
20 Mar 2019 //
FDA
Pfizer Japan recalls high blood pressure drug over cancer-causing impurity
09 Feb 2019 //
REUTERS
Sartan medicines: companies to review mfg to avoid nitrosamine impurities
01 Feb 2019 //
EMA
FDA moving to `risk-based` inspections even as valsartan scare adds new wrinkle to oversight
31 Jan 2019 //
FIERCE PHARMA
How a Tainted Heart Drug Made in China Slipped Past the FDA
30 Jan 2019 //
BLOOMBERG
Irbesartan distributed by Solco Healthcare voluntarily recalled
19 Jan 2019 //
FDA
Blood pressure drug recall: FDA investigates foreign manufacturers
14 Jan 2019 //
USA TODAY
A wave of drug recalls hits Indian pharma firms in US
09 Jan 2019 //
DNA INDIA
FDA issues alert, voluntary recall on cardiovascular medication
28 Dec 2018 //
MASSACHUSETTS LIVE
Valsartan shows manufacturing pros still have things to learn
21 Dec 2018 //
FIERCE PHARMA
Zhejiang Huahai lambasted in FDA warning for putting profits ahead of safety
12 Dec 2018 //
FIERCE PHARMA
Mylan to recall all batches of blood pressure medicine valsartan in U.S.
05 Dec 2018 //
REUTERS
Valsartan recall expands to Mylan, Teva products
29 Nov 2018 //
FIERCE PHARMA
Mylan recalls batches of blood pressure medicine in U.S.
22 Nov 2018 //
REUTERS
EU cracks down on blood pressure medicine made by Mylan
20 Nov 2018 //
REUTERS
EMA Warns of Impurity in Valsartan From Mylan
20 Nov 2018 //
RAPS
Sandoz recalls losartan products that contain impurity
12 Nov 2018 //
FIERCE PHARMA
FDA Alerts to Recalls Over Non-Valsartan Product Found to Contain Impurities
02 Nov 2018 //
RAPS
FDA warns some irbesartan tablets in U.S. contain impurity
01 Nov 2018 //
FIERCE PHARMA
EMA places Zhejiang Huahai under ‘increased supervision’ over quality issues
17 Oct 2018 //
IN-PHARMATECHNOLOGY
EMA Sartan Investigation Flags Aurobindo Pharma, Raises ZHP Oversight
16 Oct 2018 //
RAPS
EU authorities take further action in ongoing review of sartans
15 Oct 2018 //
EMA
FDA corrects previous word on Huahai import ban
12 Oct 2018 //
FIERCE PHARMA
EU, US Ban Manufacturer use of Valsartan From China’s Zhejiang Huahai
29 Sep 2018 //
RAPS
FDA halts imports from China`s Huahai after heart drug recall
29 Sep 2018 //
REUTERS
EMA review of impurities in sartan medicines
22 Sep 2018 //
PRESS RELEASE
EMA Extends Valsartan Review to Include Four More Active Substances
22 Sep 2018 //
RAPS
FDA berates Chinese drugmaker tied to global valsartan recall
22 Sep 2018 //
FIERCE PHARMA
Third Form 483 Surfaces for China Company at Center of Valsartan Contamination
21 Sep 2018 //
RAPS
Second carcinogen found in some valsartan heart meds
14 Sep 2018 //
UPI
FDA finds another impurity in recalled heart drug
14 Sep 2018 //
CNN US
Valsartan Recalls: Health Canada Spots Second Impurity
13 Sep 2018 //
RAPS
Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA
10 Sep 2018 //
HEALTH CANADA
Valsartan probe teaches FDA lesson about impurities in manufacturing
01 Sep 2018 //
FIERCE PHARMA
FDA widens valsartan probe, warns more recalls could be coming
31 Aug 2018 //
BIOPHARMADIVE
Toxin at heart of drug recall shows holes in medical safety net
23 Aug 2018 //
REUTERS
Teva Canada expands valsartan drugs recall as a precaution
22 Aug 2018 //
HEALTH CANADA
Investigation of Valsartan products for evidence of API contamination
19 Aug 2018 //
SWISSMEDIC
Update on review of valsartan medicines due to detection of NDMA
10 Aug 2018 //
EMA
Tainted valsartan has been on the market for 4 years, FDA discovers
09 Aug 2018 //
FIERCE PHARMA
FDA updates on valsartan recalls
09 Aug 2018 //
FDA
Taiwan bans blood pressure pills from China
07 Aug 2018 //
BIOSPECTRUM
Tainted valsartan has been on the market for 4 years: FDA
07 Aug 2018 //
FIERCE PHARMA
Recall of valsartan containing drugs due to contamination with carcinogen
09 Jul 2018 //
HEALTH CANADA
